American Cancer Society Announces New Research Grants For 2017 in NY and NJ

Written by Long Island News & PR  |  15. December 2016

New York, NY - December 13, 2016 - The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has approved eight new grants totaling $3,807,736 to investigators in New York and New Jersey that go into effect as of January 1, 2017.

Investigators will be using this grant money in the new year at research facilities including: Columbia University Medical Center, Memorial Sloan Kettering Cancer Center, New Jersey Medical School and New York University School of Medicine.
Currently the Society has investments of $406,873,559 in 748 unique grants across the United States.  A complete list of grants in effect by cancer type is available online.

The Society’s Chief Executive Officer, Gary Reedy, recently announced that the organization intends to double its annual research funding by 2021, which will result in an annual increase of approximately $240 million by 2021. The Society currently spends about $100 million per year in new grants to academic research institutions and another $15 to $20 million annually in research by ACS investigators in cancer epidemiology, surveillance and health services, behavioral research, and economics and health policy.

Photo courtesy of ACS.
Since 1946, the American Cancer Society has funded research and training of health professionals to investigate the causes, prevention, and early detection of cancer, as well as new treatments, cancer survivorship, and end of life support for patients and their families. In those 70 years, the American Cancer Society’s extramural research grants program has devoted more than $4.5 billion to cancer research and has funded 47 Nobel Prize winners.
For more information about the American Cancer Society Research Program, please visit http://www.cancer.org/research.
Additional information:

Copyright © 1996-2022 LongIsland.com & Long Island Media, Inc. All rights reserved.